ArticleFrontiers in pediatrics2026
Necrotizing enterocolitis: risk factors and predictive modeling in a cohort of preterm infants. A case-control study.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Necrotizing enterocolitis (NEC) is a leading cause of morbidity and mortality in preterm infants. Multiple risk factors have been reported, with inconsistent findings across studies. This study aimed to identify perinatal and postnatal risk factors associated with NEC in very preterm infants and to develop a predictive model for clinical use. Methods: We conducted a retrospective case-control study including infants <32 weeks' gestation and <1,500 g birth weight admitted to a level III NICU between 2018 and 2022. NEC was defined as stage IIA or higher according to modified Bell's criteria and diagnosed within the first 65 days of life. Demographic, clinical, and laboratory data were analysed. Multivariable logistic regression was used to identify independent predictors of NEC and to generate a nomogram. Results: Of 354 eligible infants, 46 (13%) developed NEC. NEC was significantly associated with lower gestational age and birth weight, prolonged rupture of membranes, maternal and neonatal antibiotic exposure, use of umbilical arterial catheters, vasoactive drugs, feeding intolerance, anaemia, and platelet transfusion. In multivariable analysis, early intravenous antibiotic administration within the first 24 h of life and placental abruption remained independent risk factors for NEC (OR: 1.91, 95% CI: 1.1-3.3; and OR: 2.72, 95% CI: 1.27-6.14, respectively). The predictive model demonstrated moderate discriminatory ability (AUC = 0.73, 95% CI: 0.68-0.78). Conclusion: Early intravenous antibiotic administration and placental abruption were independently associated with NEC in very preterm infants. The proposed nomogram may support early risk stratification and closer clinical surveillance using readily available clinical variables. Further multicentre studies are required to validate this predictive tool and assess its clinical utility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.